Airway smooth muscle inflammation is regulated by microRNA‐145 in COPD
Chronic obstructive pulmonary disease ( COPD ) is a common, highly debilitating disease of the airways, primarily caused by smoking. Chronic inflammation and structural remodelling are key pathological features of this disease, in part caused by the aberrant function of airway smooth muscle ( ASM )...
Ausführliche Beschreibung
Autor*in: |
O'Leary, Lawrence [verfasserIn] |
---|
Format: |
Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2016 |
---|
Rechteinformationen: |
Nutzungsrecht: © 2016 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
Enthalten in: FEBS letters - Amsterdam [u.a.] : Elsevier, 1968, 590(2016), 9, Seite 1324-1334 |
---|---|
Übergeordnetes Werk: |
volume:590 ; year:2016 ; number:9 ; pages:1324-1334 |
Links: |
---|
DOI / URN: |
10.1002/1873-3468.12168 |
---|
Katalog-ID: |
OLC1974926311 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1974926311 | ||
003 | DE-627 | ||
005 | 20230714190932.0 | ||
007 | tu | ||
008 | 160609s2016 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1002/1873-3468.12168 |2 doi | |
028 | 5 | 2 | |a PQ20160719 |
035 | |a (DE-627)OLC1974926311 | ||
035 | |a (DE-599)GBVOLC1974926311 | ||
035 | |a (PRQ)p948-1237757d858a5f8cd48b9a2f2885212d910351852cc61bc96e188315adc7f9500 | ||
035 | |a (KEY)0045922420160000590000901324airwaysmoothmuscleinflammationisregulatedbymicrorn | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 570 |a 530 |a 610 |q DNB |
100 | 1 | |a O'Leary, Lawrence |e verfasserin |4 aut | |
245 | 1 | 0 | |a Airway smooth muscle inflammation is regulated by microRNA‐145 in COPD |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
520 | |a Chronic obstructive pulmonary disease ( COPD ) is a common, highly debilitating disease of the airways, primarily caused by smoking. Chronic inflammation and structural remodelling are key pathological features of this disease, in part caused by the aberrant function of airway smooth muscle ( ASM ) cells under the regulation of transforming growth factor ( TGF )‐β. miRNA are short, noncoding gene transcripts involved in the negative regulation of specific target genes, through their interactions with mRNA. Previous studies have proposed that mRNA‐145 ( miR‐145 ) may interact with SMAD 3 , an important downstream signalling molecule of the TGF ‐β pathway. TGF ‐β was used to stimulate primary human ASM cells isolated from healthy nonsmokers, healthy smokers and COPD patients. This resulted in a TGF ‐β‐dependent increase in CXCL 8 and IL ‐6 release, most notably in the cells from COPD patients. TGF ‐β stimulation increased SMAD 3 expression, only in cells from COPD patients, with a concurrent increased miR‐145 expression. Regulation of miR‐145 was found to be negatively controlled by pathways involving the MAP kinases, MEK ‐1/2 and p38 MAPK . Subsequent, overexpression of miR‐145 (using synthetic mimics) in ASM cells from patients with COPD suppressed IL ‐6 and CXCL 8 release, to levels comparable to the nonsmoker controls. Therefore, this study suggests that miR‐145 negatively regulates pro‐inflammatory cytokine release from ASM cells in COPD by targeting SMAD 3 . | ||
540 | |a Nutzungsrecht: © 2016 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. | ||
650 | 4 | |a inflammation | |
650 | 4 | |a RNA | |
650 | 4 | |a micro | |
650 | 4 | |a COPD | |
700 | 1 | |a Sevinç, Kenan |4 oth | |
700 | 1 | |a Papazoglou, Ilektra M |4 oth | |
700 | 1 | |a Tildy, Bernadett |4 oth | |
700 | 1 | |a Detillieux, Karen |4 oth | |
700 | 1 | |a Halayko, Andrew J |4 oth | |
700 | 1 | |a Chung, Kian Fan |4 oth | |
700 | 1 | |a Perry, Mark M |4 oth | |
773 | 0 | 8 | |i Enthalten in |t FEBS letters |d Amsterdam [u.a.] : Elsevier, 1968 |g 590(2016), 9, Seite 1324-1334 |w (DE-627)129522023 |w (DE-600)212746-5 |w (DE-576)014938014 |x 0014-5793 |7 nnns |
773 | 1 | 8 | |g volume:590 |g year:2016 |g number:9 |g pages:1324-1334 |
856 | 4 | 1 | |u http://dx.doi.org/10.1002/1873-3468.12168 |3 Volltext |
856 | 4 | 2 | |u http://onlinelibrary.wiley.com/doi/10.1002/1873-3468.12168/abstract |
856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/27060571 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHY | ||
912 | |a SSG-OLC-CHE | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
951 | |a AR | ||
952 | |d 590 |j 2016 |e 9 |h 1324-1334 |
author_variant |
l o lo |
---|---|
matchkey_str |
article:00145793:2016----::iwymohucenlmainseuaebm |
hierarchy_sort_str |
2016 |
publishDate |
2016 |
allfields |
10.1002/1873-3468.12168 doi PQ20160719 (DE-627)OLC1974926311 (DE-599)GBVOLC1974926311 (PRQ)p948-1237757d858a5f8cd48b9a2f2885212d910351852cc61bc96e188315adc7f9500 (KEY)0045922420160000590000901324airwaysmoothmuscleinflammationisregulatedbymicrorn DE-627 ger DE-627 rakwb eng 570 530 610 DNB O'Leary, Lawrence verfasserin aut Airway smooth muscle inflammation is regulated by microRNA‐145 in COPD 2016 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Chronic obstructive pulmonary disease ( COPD ) is a common, highly debilitating disease of the airways, primarily caused by smoking. Chronic inflammation and structural remodelling are key pathological features of this disease, in part caused by the aberrant function of airway smooth muscle ( ASM ) cells under the regulation of transforming growth factor ( TGF )‐β. miRNA are short, noncoding gene transcripts involved in the negative regulation of specific target genes, through their interactions with mRNA. Previous studies have proposed that mRNA‐145 ( miR‐145 ) may interact with SMAD 3 , an important downstream signalling molecule of the TGF ‐β pathway. TGF ‐β was used to stimulate primary human ASM cells isolated from healthy nonsmokers, healthy smokers and COPD patients. This resulted in a TGF ‐β‐dependent increase in CXCL 8 and IL ‐6 release, most notably in the cells from COPD patients. TGF ‐β stimulation increased SMAD 3 expression, only in cells from COPD patients, with a concurrent increased miR‐145 expression. Regulation of miR‐145 was found to be negatively controlled by pathways involving the MAP kinases, MEK ‐1/2 and p38 MAPK . Subsequent, overexpression of miR‐145 (using synthetic mimics) in ASM cells from patients with COPD suppressed IL ‐6 and CXCL 8 release, to levels comparable to the nonsmoker controls. Therefore, this study suggests that miR‐145 negatively regulates pro‐inflammatory cytokine release from ASM cells in COPD by targeting SMAD 3 . Nutzungsrecht: © 2016 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. inflammation RNA micro COPD Sevinç, Kenan oth Papazoglou, Ilektra M oth Tildy, Bernadett oth Detillieux, Karen oth Halayko, Andrew J oth Chung, Kian Fan oth Perry, Mark M oth Enthalten in FEBS letters Amsterdam [u.a.] : Elsevier, 1968 590(2016), 9, Seite 1324-1334 (DE-627)129522023 (DE-600)212746-5 (DE-576)014938014 0014-5793 nnns volume:590 year:2016 number:9 pages:1324-1334 http://dx.doi.org/10.1002/1873-3468.12168 Volltext http://onlinelibrary.wiley.com/doi/10.1002/1873-3468.12168/abstract http://www.ncbi.nlm.nih.gov/pubmed/27060571 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-PHY SSG-OLC-CHE SSG-OLC-PHA SSG-OLC-DE-84 AR 590 2016 9 1324-1334 |
spelling |
10.1002/1873-3468.12168 doi PQ20160719 (DE-627)OLC1974926311 (DE-599)GBVOLC1974926311 (PRQ)p948-1237757d858a5f8cd48b9a2f2885212d910351852cc61bc96e188315adc7f9500 (KEY)0045922420160000590000901324airwaysmoothmuscleinflammationisregulatedbymicrorn DE-627 ger DE-627 rakwb eng 570 530 610 DNB O'Leary, Lawrence verfasserin aut Airway smooth muscle inflammation is regulated by microRNA‐145 in COPD 2016 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Chronic obstructive pulmonary disease ( COPD ) is a common, highly debilitating disease of the airways, primarily caused by smoking. Chronic inflammation and structural remodelling are key pathological features of this disease, in part caused by the aberrant function of airway smooth muscle ( ASM ) cells under the regulation of transforming growth factor ( TGF )‐β. miRNA are short, noncoding gene transcripts involved in the negative regulation of specific target genes, through their interactions with mRNA. Previous studies have proposed that mRNA‐145 ( miR‐145 ) may interact with SMAD 3 , an important downstream signalling molecule of the TGF ‐β pathway. TGF ‐β was used to stimulate primary human ASM cells isolated from healthy nonsmokers, healthy smokers and COPD patients. This resulted in a TGF ‐β‐dependent increase in CXCL 8 and IL ‐6 release, most notably in the cells from COPD patients. TGF ‐β stimulation increased SMAD 3 expression, only in cells from COPD patients, with a concurrent increased miR‐145 expression. Regulation of miR‐145 was found to be negatively controlled by pathways involving the MAP kinases, MEK ‐1/2 and p38 MAPK . Subsequent, overexpression of miR‐145 (using synthetic mimics) in ASM cells from patients with COPD suppressed IL ‐6 and CXCL 8 release, to levels comparable to the nonsmoker controls. Therefore, this study suggests that miR‐145 negatively regulates pro‐inflammatory cytokine release from ASM cells in COPD by targeting SMAD 3 . Nutzungsrecht: © 2016 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. inflammation RNA micro COPD Sevinç, Kenan oth Papazoglou, Ilektra M oth Tildy, Bernadett oth Detillieux, Karen oth Halayko, Andrew J oth Chung, Kian Fan oth Perry, Mark M oth Enthalten in FEBS letters Amsterdam [u.a.] : Elsevier, 1968 590(2016), 9, Seite 1324-1334 (DE-627)129522023 (DE-600)212746-5 (DE-576)014938014 0014-5793 nnns volume:590 year:2016 number:9 pages:1324-1334 http://dx.doi.org/10.1002/1873-3468.12168 Volltext http://onlinelibrary.wiley.com/doi/10.1002/1873-3468.12168/abstract http://www.ncbi.nlm.nih.gov/pubmed/27060571 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-PHY SSG-OLC-CHE SSG-OLC-PHA SSG-OLC-DE-84 AR 590 2016 9 1324-1334 |
allfields_unstemmed |
10.1002/1873-3468.12168 doi PQ20160719 (DE-627)OLC1974926311 (DE-599)GBVOLC1974926311 (PRQ)p948-1237757d858a5f8cd48b9a2f2885212d910351852cc61bc96e188315adc7f9500 (KEY)0045922420160000590000901324airwaysmoothmuscleinflammationisregulatedbymicrorn DE-627 ger DE-627 rakwb eng 570 530 610 DNB O'Leary, Lawrence verfasserin aut Airway smooth muscle inflammation is regulated by microRNA‐145 in COPD 2016 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Chronic obstructive pulmonary disease ( COPD ) is a common, highly debilitating disease of the airways, primarily caused by smoking. Chronic inflammation and structural remodelling are key pathological features of this disease, in part caused by the aberrant function of airway smooth muscle ( ASM ) cells under the regulation of transforming growth factor ( TGF )‐β. miRNA are short, noncoding gene transcripts involved in the negative regulation of specific target genes, through their interactions with mRNA. Previous studies have proposed that mRNA‐145 ( miR‐145 ) may interact with SMAD 3 , an important downstream signalling molecule of the TGF ‐β pathway. TGF ‐β was used to stimulate primary human ASM cells isolated from healthy nonsmokers, healthy smokers and COPD patients. This resulted in a TGF ‐β‐dependent increase in CXCL 8 and IL ‐6 release, most notably in the cells from COPD patients. TGF ‐β stimulation increased SMAD 3 expression, only in cells from COPD patients, with a concurrent increased miR‐145 expression. Regulation of miR‐145 was found to be negatively controlled by pathways involving the MAP kinases, MEK ‐1/2 and p38 MAPK . Subsequent, overexpression of miR‐145 (using synthetic mimics) in ASM cells from patients with COPD suppressed IL ‐6 and CXCL 8 release, to levels comparable to the nonsmoker controls. Therefore, this study suggests that miR‐145 negatively regulates pro‐inflammatory cytokine release from ASM cells in COPD by targeting SMAD 3 . Nutzungsrecht: © 2016 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. inflammation RNA micro COPD Sevinç, Kenan oth Papazoglou, Ilektra M oth Tildy, Bernadett oth Detillieux, Karen oth Halayko, Andrew J oth Chung, Kian Fan oth Perry, Mark M oth Enthalten in FEBS letters Amsterdam [u.a.] : Elsevier, 1968 590(2016), 9, Seite 1324-1334 (DE-627)129522023 (DE-600)212746-5 (DE-576)014938014 0014-5793 nnns volume:590 year:2016 number:9 pages:1324-1334 http://dx.doi.org/10.1002/1873-3468.12168 Volltext http://onlinelibrary.wiley.com/doi/10.1002/1873-3468.12168/abstract http://www.ncbi.nlm.nih.gov/pubmed/27060571 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-PHY SSG-OLC-CHE SSG-OLC-PHA SSG-OLC-DE-84 AR 590 2016 9 1324-1334 |
allfieldsGer |
10.1002/1873-3468.12168 doi PQ20160719 (DE-627)OLC1974926311 (DE-599)GBVOLC1974926311 (PRQ)p948-1237757d858a5f8cd48b9a2f2885212d910351852cc61bc96e188315adc7f9500 (KEY)0045922420160000590000901324airwaysmoothmuscleinflammationisregulatedbymicrorn DE-627 ger DE-627 rakwb eng 570 530 610 DNB O'Leary, Lawrence verfasserin aut Airway smooth muscle inflammation is regulated by microRNA‐145 in COPD 2016 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Chronic obstructive pulmonary disease ( COPD ) is a common, highly debilitating disease of the airways, primarily caused by smoking. Chronic inflammation and structural remodelling are key pathological features of this disease, in part caused by the aberrant function of airway smooth muscle ( ASM ) cells under the regulation of transforming growth factor ( TGF )‐β. miRNA are short, noncoding gene transcripts involved in the negative regulation of specific target genes, through their interactions with mRNA. Previous studies have proposed that mRNA‐145 ( miR‐145 ) may interact with SMAD 3 , an important downstream signalling molecule of the TGF ‐β pathway. TGF ‐β was used to stimulate primary human ASM cells isolated from healthy nonsmokers, healthy smokers and COPD patients. This resulted in a TGF ‐β‐dependent increase in CXCL 8 and IL ‐6 release, most notably in the cells from COPD patients. TGF ‐β stimulation increased SMAD 3 expression, only in cells from COPD patients, with a concurrent increased miR‐145 expression. Regulation of miR‐145 was found to be negatively controlled by pathways involving the MAP kinases, MEK ‐1/2 and p38 MAPK . Subsequent, overexpression of miR‐145 (using synthetic mimics) in ASM cells from patients with COPD suppressed IL ‐6 and CXCL 8 release, to levels comparable to the nonsmoker controls. Therefore, this study suggests that miR‐145 negatively regulates pro‐inflammatory cytokine release from ASM cells in COPD by targeting SMAD 3 . Nutzungsrecht: © 2016 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. inflammation RNA micro COPD Sevinç, Kenan oth Papazoglou, Ilektra M oth Tildy, Bernadett oth Detillieux, Karen oth Halayko, Andrew J oth Chung, Kian Fan oth Perry, Mark M oth Enthalten in FEBS letters Amsterdam [u.a.] : Elsevier, 1968 590(2016), 9, Seite 1324-1334 (DE-627)129522023 (DE-600)212746-5 (DE-576)014938014 0014-5793 nnns volume:590 year:2016 number:9 pages:1324-1334 http://dx.doi.org/10.1002/1873-3468.12168 Volltext http://onlinelibrary.wiley.com/doi/10.1002/1873-3468.12168/abstract http://www.ncbi.nlm.nih.gov/pubmed/27060571 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-PHY SSG-OLC-CHE SSG-OLC-PHA SSG-OLC-DE-84 AR 590 2016 9 1324-1334 |
allfieldsSound |
10.1002/1873-3468.12168 doi PQ20160719 (DE-627)OLC1974926311 (DE-599)GBVOLC1974926311 (PRQ)p948-1237757d858a5f8cd48b9a2f2885212d910351852cc61bc96e188315adc7f9500 (KEY)0045922420160000590000901324airwaysmoothmuscleinflammationisregulatedbymicrorn DE-627 ger DE-627 rakwb eng 570 530 610 DNB O'Leary, Lawrence verfasserin aut Airway smooth muscle inflammation is regulated by microRNA‐145 in COPD 2016 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Chronic obstructive pulmonary disease ( COPD ) is a common, highly debilitating disease of the airways, primarily caused by smoking. Chronic inflammation and structural remodelling are key pathological features of this disease, in part caused by the aberrant function of airway smooth muscle ( ASM ) cells under the regulation of transforming growth factor ( TGF )‐β. miRNA are short, noncoding gene transcripts involved in the negative regulation of specific target genes, through their interactions with mRNA. Previous studies have proposed that mRNA‐145 ( miR‐145 ) may interact with SMAD 3 , an important downstream signalling molecule of the TGF ‐β pathway. TGF ‐β was used to stimulate primary human ASM cells isolated from healthy nonsmokers, healthy smokers and COPD patients. This resulted in a TGF ‐β‐dependent increase in CXCL 8 and IL ‐6 release, most notably in the cells from COPD patients. TGF ‐β stimulation increased SMAD 3 expression, only in cells from COPD patients, with a concurrent increased miR‐145 expression. Regulation of miR‐145 was found to be negatively controlled by pathways involving the MAP kinases, MEK ‐1/2 and p38 MAPK . Subsequent, overexpression of miR‐145 (using synthetic mimics) in ASM cells from patients with COPD suppressed IL ‐6 and CXCL 8 release, to levels comparable to the nonsmoker controls. Therefore, this study suggests that miR‐145 negatively regulates pro‐inflammatory cytokine release from ASM cells in COPD by targeting SMAD 3 . Nutzungsrecht: © 2016 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. inflammation RNA micro COPD Sevinç, Kenan oth Papazoglou, Ilektra M oth Tildy, Bernadett oth Detillieux, Karen oth Halayko, Andrew J oth Chung, Kian Fan oth Perry, Mark M oth Enthalten in FEBS letters Amsterdam [u.a.] : Elsevier, 1968 590(2016), 9, Seite 1324-1334 (DE-627)129522023 (DE-600)212746-5 (DE-576)014938014 0014-5793 nnns volume:590 year:2016 number:9 pages:1324-1334 http://dx.doi.org/10.1002/1873-3468.12168 Volltext http://onlinelibrary.wiley.com/doi/10.1002/1873-3468.12168/abstract http://www.ncbi.nlm.nih.gov/pubmed/27060571 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-PHY SSG-OLC-CHE SSG-OLC-PHA SSG-OLC-DE-84 AR 590 2016 9 1324-1334 |
language |
English |
source |
Enthalten in FEBS letters 590(2016), 9, Seite 1324-1334 volume:590 year:2016 number:9 pages:1324-1334 |
sourceStr |
Enthalten in FEBS letters 590(2016), 9, Seite 1324-1334 volume:590 year:2016 number:9 pages:1324-1334 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
inflammation RNA micro COPD |
dewey-raw |
570 |
isfreeaccess_bool |
false |
container_title |
FEBS letters |
authorswithroles_txt_mv |
O'Leary, Lawrence @@aut@@ Sevinç, Kenan @@oth@@ Papazoglou, Ilektra M @@oth@@ Tildy, Bernadett @@oth@@ Detillieux, Karen @@oth@@ Halayko, Andrew J @@oth@@ Chung, Kian Fan @@oth@@ Perry, Mark M @@oth@@ |
publishDateDaySort_date |
2016-01-01T00:00:00Z |
hierarchy_top_id |
129522023 |
dewey-sort |
3570 |
id |
OLC1974926311 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a2200265 4500</leader><controlfield tag="001">OLC1974926311</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230714190932.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">160609s2016 xx ||||| 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1002/1873-3468.12168</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">PQ20160719</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC1974926311</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVOLC1974926311</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PRQ)p948-1237757d858a5f8cd48b9a2f2885212d910351852cc61bc96e188315adc7f9500</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(KEY)0045922420160000590000901324airwaysmoothmuscleinflammationisregulatedbymicrorn</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">530</subfield><subfield code="a">610</subfield><subfield code="q">DNB</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">O'Leary, Lawrence</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Airway smooth muscle inflammation is regulated by microRNA‐145 in COPD</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Chronic obstructive pulmonary disease ( COPD ) is a common, highly debilitating disease of the airways, primarily caused by smoking. Chronic inflammation and structural remodelling are key pathological features of this disease, in part caused by the aberrant function of airway smooth muscle ( ASM ) cells under the regulation of transforming growth factor ( TGF )‐β. miRNA are short, noncoding gene transcripts involved in the negative regulation of specific target genes, through their interactions with mRNA. Previous studies have proposed that mRNA‐145 ( miR‐145 ) may interact with SMAD 3 , an important downstream signalling molecule of the TGF ‐β pathway. TGF ‐β was used to stimulate primary human ASM cells isolated from healthy nonsmokers, healthy smokers and COPD patients. This resulted in a TGF ‐β‐dependent increase in CXCL 8 and IL ‐6 release, most notably in the cells from COPD patients. TGF ‐β stimulation increased SMAD 3 expression, only in cells from COPD patients, with a concurrent increased miR‐145 expression. Regulation of miR‐145 was found to be negatively controlled by pathways involving the MAP kinases, MEK ‐1/2 and p38 MAPK . Subsequent, overexpression of miR‐145 (using synthetic mimics) in ASM cells from patients with COPD suppressed IL ‐6 and CXCL 8 release, to levels comparable to the nonsmoker controls. Therefore, this study suggests that miR‐145 negatively regulates pro‐inflammatory cytokine release from ASM cells in COPD by targeting SMAD 3 .</subfield></datafield><datafield tag="540" ind1=" " ind2=" "><subfield code="a">Nutzungsrecht: © 2016 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">inflammation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">RNA</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">micro</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">COPD</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sevinç, Kenan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Papazoglou, Ilektra M</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tildy, Bernadett</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Detillieux, Karen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Halayko, Andrew J</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chung, Kian Fan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Perry, Mark M</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">FEBS letters</subfield><subfield code="d">Amsterdam [u.a.] : Elsevier, 1968</subfield><subfield code="g">590(2016), 9, Seite 1324-1334</subfield><subfield code="w">(DE-627)129522023</subfield><subfield code="w">(DE-600)212746-5</subfield><subfield code="w">(DE-576)014938014</subfield><subfield code="x">0014-5793</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:590</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:9</subfield><subfield code="g">pages:1324-1334</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://dx.doi.org/10.1002/1873-3468.12168</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">http://onlinelibrary.wiley.com/doi/10.1002/1873-3468.12168/abstract</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">http://www.ncbi.nlm.nih.gov/pubmed/27060571</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-CHE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-DE-84</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">590</subfield><subfield code="j">2016</subfield><subfield code="e">9</subfield><subfield code="h">1324-1334</subfield></datafield></record></collection>
|
author |
O'Leary, Lawrence |
spellingShingle |
O'Leary, Lawrence ddc 570 misc inflammation misc RNA misc micro misc COPD Airway smooth muscle inflammation is regulated by microRNA‐145 in COPD |
authorStr |
O'Leary, Lawrence |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)129522023 |
format |
Article |
dewey-ones |
570 - Life sciences; biology 530 - Physics 610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
OLC |
remote_str |
false |
illustrated |
Not Illustrated |
issn |
0014-5793 |
topic_title |
570 530 610 DNB Airway smooth muscle inflammation is regulated by microRNA‐145 in COPD inflammation RNA micro COPD |
topic |
ddc 570 misc inflammation misc RNA misc micro misc COPD |
topic_unstemmed |
ddc 570 misc inflammation misc RNA misc micro misc COPD |
topic_browse |
ddc 570 misc inflammation misc RNA misc micro misc COPD |
format_facet |
Aufsätze Gedruckte Aufsätze |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
nc |
author2_variant |
k s ks i m p im imp b t bt k d kd a j h aj ajh k f c kf kfc m m p mm mmp |
hierarchy_parent_title |
FEBS letters |
hierarchy_parent_id |
129522023 |
dewey-tens |
570 - Life sciences; biology 530 - Physics 610 - Medicine & health |
hierarchy_top_title |
FEBS letters |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)129522023 (DE-600)212746-5 (DE-576)014938014 |
title |
Airway smooth muscle inflammation is regulated by microRNA‐145 in COPD |
ctrlnum |
(DE-627)OLC1974926311 (DE-599)GBVOLC1974926311 (PRQ)p948-1237757d858a5f8cd48b9a2f2885212d910351852cc61bc96e188315adc7f9500 (KEY)0045922420160000590000901324airwaysmoothmuscleinflammationisregulatedbymicrorn |
title_full |
Airway smooth muscle inflammation is regulated by microRNA‐145 in COPD |
author_sort |
O'Leary, Lawrence |
journal |
FEBS letters |
journalStr |
FEBS letters |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
500 - Science 600 - Technology |
recordtype |
marc |
publishDateSort |
2016 |
contenttype_str_mv |
txt |
container_start_page |
1324 |
author_browse |
O'Leary, Lawrence |
container_volume |
590 |
class |
570 530 610 DNB |
format_se |
Aufsätze |
author-letter |
O'Leary, Lawrence |
doi_str_mv |
10.1002/1873-3468.12168 |
dewey-full |
570 530 610 |
title_sort |
airway smooth muscle inflammation is regulated by microrna‐145 in copd |
title_auth |
Airway smooth muscle inflammation is regulated by microRNA‐145 in COPD |
abstract |
Chronic obstructive pulmonary disease ( COPD ) is a common, highly debilitating disease of the airways, primarily caused by smoking. Chronic inflammation and structural remodelling are key pathological features of this disease, in part caused by the aberrant function of airway smooth muscle ( ASM ) cells under the regulation of transforming growth factor ( TGF )‐β. miRNA are short, noncoding gene transcripts involved in the negative regulation of specific target genes, through their interactions with mRNA. Previous studies have proposed that mRNA‐145 ( miR‐145 ) may interact with SMAD 3 , an important downstream signalling molecule of the TGF ‐β pathway. TGF ‐β was used to stimulate primary human ASM cells isolated from healthy nonsmokers, healthy smokers and COPD patients. This resulted in a TGF ‐β‐dependent increase in CXCL 8 and IL ‐6 release, most notably in the cells from COPD patients. TGF ‐β stimulation increased SMAD 3 expression, only in cells from COPD patients, with a concurrent increased miR‐145 expression. Regulation of miR‐145 was found to be negatively controlled by pathways involving the MAP kinases, MEK ‐1/2 and p38 MAPK . Subsequent, overexpression of miR‐145 (using synthetic mimics) in ASM cells from patients with COPD suppressed IL ‐6 and CXCL 8 release, to levels comparable to the nonsmoker controls. Therefore, this study suggests that miR‐145 negatively regulates pro‐inflammatory cytokine release from ASM cells in COPD by targeting SMAD 3 . |
abstractGer |
Chronic obstructive pulmonary disease ( COPD ) is a common, highly debilitating disease of the airways, primarily caused by smoking. Chronic inflammation and structural remodelling are key pathological features of this disease, in part caused by the aberrant function of airway smooth muscle ( ASM ) cells under the regulation of transforming growth factor ( TGF )‐β. miRNA are short, noncoding gene transcripts involved in the negative regulation of specific target genes, through their interactions with mRNA. Previous studies have proposed that mRNA‐145 ( miR‐145 ) may interact with SMAD 3 , an important downstream signalling molecule of the TGF ‐β pathway. TGF ‐β was used to stimulate primary human ASM cells isolated from healthy nonsmokers, healthy smokers and COPD patients. This resulted in a TGF ‐β‐dependent increase in CXCL 8 and IL ‐6 release, most notably in the cells from COPD patients. TGF ‐β stimulation increased SMAD 3 expression, only in cells from COPD patients, with a concurrent increased miR‐145 expression. Regulation of miR‐145 was found to be negatively controlled by pathways involving the MAP kinases, MEK ‐1/2 and p38 MAPK . Subsequent, overexpression of miR‐145 (using synthetic mimics) in ASM cells from patients with COPD suppressed IL ‐6 and CXCL 8 release, to levels comparable to the nonsmoker controls. Therefore, this study suggests that miR‐145 negatively regulates pro‐inflammatory cytokine release from ASM cells in COPD by targeting SMAD 3 . |
abstract_unstemmed |
Chronic obstructive pulmonary disease ( COPD ) is a common, highly debilitating disease of the airways, primarily caused by smoking. Chronic inflammation and structural remodelling are key pathological features of this disease, in part caused by the aberrant function of airway smooth muscle ( ASM ) cells under the regulation of transforming growth factor ( TGF )‐β. miRNA are short, noncoding gene transcripts involved in the negative regulation of specific target genes, through their interactions with mRNA. Previous studies have proposed that mRNA‐145 ( miR‐145 ) may interact with SMAD 3 , an important downstream signalling molecule of the TGF ‐β pathway. TGF ‐β was used to stimulate primary human ASM cells isolated from healthy nonsmokers, healthy smokers and COPD patients. This resulted in a TGF ‐β‐dependent increase in CXCL 8 and IL ‐6 release, most notably in the cells from COPD patients. TGF ‐β stimulation increased SMAD 3 expression, only in cells from COPD patients, with a concurrent increased miR‐145 expression. Regulation of miR‐145 was found to be negatively controlled by pathways involving the MAP kinases, MEK ‐1/2 and p38 MAPK . Subsequent, overexpression of miR‐145 (using synthetic mimics) in ASM cells from patients with COPD suppressed IL ‐6 and CXCL 8 release, to levels comparable to the nonsmoker controls. Therefore, this study suggests that miR‐145 negatively regulates pro‐inflammatory cytokine release from ASM cells in COPD by targeting SMAD 3 . |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-PHY SSG-OLC-CHE SSG-OLC-PHA SSG-OLC-DE-84 |
container_issue |
9 |
title_short |
Airway smooth muscle inflammation is regulated by microRNA‐145 in COPD |
url |
http://dx.doi.org/10.1002/1873-3468.12168 http://onlinelibrary.wiley.com/doi/10.1002/1873-3468.12168/abstract http://www.ncbi.nlm.nih.gov/pubmed/27060571 |
remote_bool |
false |
author2 |
Sevinç, Kenan Papazoglou, Ilektra M Tildy, Bernadett Detillieux, Karen Halayko, Andrew J Chung, Kian Fan Perry, Mark M |
author2Str |
Sevinç, Kenan Papazoglou, Ilektra M Tildy, Bernadett Detillieux, Karen Halayko, Andrew J Chung, Kian Fan Perry, Mark M |
ppnlink |
129522023 |
mediatype_str_mv |
n |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth oth |
doi_str |
10.1002/1873-3468.12168 |
up_date |
2024-07-04T05:23:30.698Z |
_version_ |
1803624760671731712 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a2200265 4500</leader><controlfield tag="001">OLC1974926311</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230714190932.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">160609s2016 xx ||||| 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1002/1873-3468.12168</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">PQ20160719</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC1974926311</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVOLC1974926311</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PRQ)p948-1237757d858a5f8cd48b9a2f2885212d910351852cc61bc96e188315adc7f9500</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(KEY)0045922420160000590000901324airwaysmoothmuscleinflammationisregulatedbymicrorn</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">530</subfield><subfield code="a">610</subfield><subfield code="q">DNB</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">O'Leary, Lawrence</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Airway smooth muscle inflammation is regulated by microRNA‐145 in COPD</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Chronic obstructive pulmonary disease ( COPD ) is a common, highly debilitating disease of the airways, primarily caused by smoking. Chronic inflammation and structural remodelling are key pathological features of this disease, in part caused by the aberrant function of airway smooth muscle ( ASM ) cells under the regulation of transforming growth factor ( TGF )‐β. miRNA are short, noncoding gene transcripts involved in the negative regulation of specific target genes, through their interactions with mRNA. Previous studies have proposed that mRNA‐145 ( miR‐145 ) may interact with SMAD 3 , an important downstream signalling molecule of the TGF ‐β pathway. TGF ‐β was used to stimulate primary human ASM cells isolated from healthy nonsmokers, healthy smokers and COPD patients. This resulted in a TGF ‐β‐dependent increase in CXCL 8 and IL ‐6 release, most notably in the cells from COPD patients. TGF ‐β stimulation increased SMAD 3 expression, only in cells from COPD patients, with a concurrent increased miR‐145 expression. Regulation of miR‐145 was found to be negatively controlled by pathways involving the MAP kinases, MEK ‐1/2 and p38 MAPK . Subsequent, overexpression of miR‐145 (using synthetic mimics) in ASM cells from patients with COPD suppressed IL ‐6 and CXCL 8 release, to levels comparable to the nonsmoker controls. Therefore, this study suggests that miR‐145 negatively regulates pro‐inflammatory cytokine release from ASM cells in COPD by targeting SMAD 3 .</subfield></datafield><datafield tag="540" ind1=" " ind2=" "><subfield code="a">Nutzungsrecht: © 2016 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">inflammation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">RNA</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">micro</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">COPD</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sevinç, Kenan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Papazoglou, Ilektra M</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tildy, Bernadett</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Detillieux, Karen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Halayko, Andrew J</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chung, Kian Fan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Perry, Mark M</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">FEBS letters</subfield><subfield code="d">Amsterdam [u.a.] : Elsevier, 1968</subfield><subfield code="g">590(2016), 9, Seite 1324-1334</subfield><subfield code="w">(DE-627)129522023</subfield><subfield code="w">(DE-600)212746-5</subfield><subfield code="w">(DE-576)014938014</subfield><subfield code="x">0014-5793</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:590</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:9</subfield><subfield code="g">pages:1324-1334</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://dx.doi.org/10.1002/1873-3468.12168</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">http://onlinelibrary.wiley.com/doi/10.1002/1873-3468.12168/abstract</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">http://www.ncbi.nlm.nih.gov/pubmed/27060571</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-CHE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-DE-84</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">590</subfield><subfield code="j">2016</subfield><subfield code="e">9</subfield><subfield code="h">1324-1334</subfield></datafield></record></collection>
|
score |
7.397525 |